A 7-year experience in adenoidectomy with endoscopic radiofrequency volume reduction

To evaluate the effectiveness, safety, and postoperative outcomes of endoscopic radiofrequency adenoidectomy in pediatric patients over seven years. This study was conducted at the University Hospitals between May 2017 and August 2024. This prospective observational case series included pediatric patients who underwent endoscopic radiofrequency adenoidectomy due to adenoid hypertrophy and related complications. Preoperative evaluation included clinical assessment, nasal endoscopy, and imaging. Intraoperative data, including blood loss and operative time, and postoperative outcomes, such as pain, bleeding, and halitosis, were recorded. The mean operative time was 15 min, and the mean blood loss was 31 ml (p = 0.0001). Postoperative pain decreased significantly over time (p = 0.0001). Primary bleeding occurred in 0.3% of cases. Halitosis affected 2% of patients during the first week but was reduced by the first month (p = 0.0001). Endoscopic radiofrequency adenoidectomy is a safe, efficient, and minimally invasive approach for managing adenoid hypertrophy in pediatric patients. It offers minimal blood loss, rapid recovery, and low complication rates.